Baogen Lu

822 total citations
18 papers, 681 citations indexed

About

Baogen Lu is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Baogen Lu has authored 18 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Baogen Lu's work include Virus-based gene therapy research (14 papers), RNA Interference and Gene Delivery (7 papers) and Immunotherapy and Immune Responses (4 papers). Baogen Lu is often cited by papers focused on Virus-based gene therapy research (14 papers), RNA Interference and Gene Delivery (7 papers) and Immunotherapy and Immune Responses (4 papers). Baogen Lu collaborates with scholars based in United States, France and Australia. Baogen Lu's co-authors include Zeng B. Zhu, David T. Curiel, Sharmila Makhija, Yong Zhou, Minghui Wang, Ronald D. Alvarez, W. David Merryman, Joanne E. Murphy-Ullrich, James S. Hagood and Gene P. Siegal and has published in prestigious journals such as Journal of Biological Chemistry, Journal of neurosurgery and American Journal Of Pathology.

In The Last Decade

Baogen Lu

18 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baogen Lu United States 14 388 317 223 103 85 18 681
Wolfgang Ebel United States 9 285 0.7× 144 0.5× 190 0.9× 138 1.3× 79 0.9× 11 675
Friederike Herbst Germany 12 545 1.4× 160 0.5× 467 2.1× 52 0.5× 36 0.4× 34 977
Radhashree Maitra United States 16 347 0.9× 167 0.5× 295 1.3× 68 0.7× 79 0.9× 57 773
Kenneth Garson Canada 17 386 1.0× 209 0.7× 160 0.7× 29 0.3× 31 0.4× 28 708
Joseph Briggs United States 14 414 1.1× 85 0.3× 177 0.8× 97 0.9× 46 0.5× 17 656
Gary Owen United Kingdom 6 413 1.1× 193 0.6× 383 1.7× 76 0.7× 36 0.4× 10 800
Chelsea K. Martin United States 15 269 0.7× 100 0.3× 265 1.2× 226 2.2× 41 0.5× 27 760
Joelle M. Fenger United States 13 542 1.4× 210 0.7× 227 1.0× 347 3.4× 66 0.8× 32 1000
Natalie Erdmann Canada 13 768 2.0× 135 0.4× 220 1.0× 42 0.4× 42 0.5× 18 1.1k
Alexis J. Carulli United States 6 407 1.0× 216 0.7× 341 1.5× 48 0.5× 20 0.2× 8 809

Countries citing papers authored by Baogen Lu

Since Specialization
Citations

This map shows the geographic impact of Baogen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baogen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baogen Lu more than expected).

Fields of papers citing papers by Baogen Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baogen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baogen Lu. The network helps show where Baogen Lu may publish in the future.

Co-authorship network of co-authors of Baogen Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Baogen Lu. A scholar is included among the top collaborators of Baogen Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baogen Lu. Baogen Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jolly, Pauline E., Seidu Inusah, Baogen Lu, et al.. (2013). Association between high aflatoxin B1 levels and high viral load in HIV-positive people. World Mycotoxin Journal. 6(3). 255–261. 31 indexed citations
2.
Huang, Xiangwei, et al.. (2011). Relaxin Regulates Myofibroblast Contractility and Protects against Lung Fibrosis. American Journal Of Pathology. 179(6). 2751–2765. 73 indexed citations
3.
Zhou, Yong, James S. Hagood, Baogen Lu, W. David Merryman, & Joanne E. Murphy-Ullrich. (2010). Thy-1-Integrin αvβ5 Interactions Inhibit Lung Fibroblast Contraction-induced Latent Transforming Growth Factor-β1 Activation and Myofibroblast Differentiation. Journal of Biological Chemistry. 285(29). 22382–22393. 106 indexed citations
4.
Curiel, David T., Hongju Wu, Ronald D. Alvarez, et al.. (2008). Development of an optimized conditionally replicative adenoviral agent for ovarian cancer. International Journal of Oncology. 6 indexed citations
5.
Numnum, T. Michael, Sharmila Makhija, Baogen Lu, et al.. (2007). Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines. Gynecologic Oncology. 108(1). 34–41. 17 indexed citations
6.
Rosenthal, Eben L., Shaonin Ji, Baogen Lu, et al.. (2007). Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck. International Journal of Oncology. 31(5). 1213–22. 13 indexed citations
7.
Zhu, Zeng B., Sharmila Makhija, Baogen Lu, et al.. (2006). Targeting Mesothelioma Using an Infectivity Enhanced Survivin-Conditionally Replicative Adenoviruses. Journal of Thoracic Oncology. 1(7). 701–711. 13 indexed citations
8.
Zhu, Zeng B., Ángel A. Rivera, Sharmila Makhija, et al.. (2006). Targeting lung cancer using an infectivity enhanced CXCR4-CRAd. Lung Cancer. 55(2). 145–156. 10 indexed citations
9.
Houdt, Winan J. van, Yosef S. Haviv, Baogen Lu, et al.. (2006). The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma. Journal of neurosurgery. 104(4). 583–592. 69 indexed citations
10.
Rocconi, Rodney P., Zeng B. Zhu, Baogen Lu, et al.. (2006). Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapy. Gynecologic Oncology. 103(3). 985–989. 2 indexed citations
11.
Zhu, Zeng B., Yabing Chen, Sharmila Makhija, et al.. (2006). Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma. International Journal of Oncology. 29(5). 1319–29. 35 indexed citations
12.
Zhu, Zeng B., Sharmila Makhija, Baogen Lu, et al.. (2006). Targeting Mesothelioma Using an Infectivity Enhanced Survivin-Conditionally Replicative Adenoviruses. Journal of Thoracic Oncology. 1(7). 701–711. 23 indexed citations
13.
Zhu, Zeng B., Sharmila Makhija, Baogen Lu, et al.. (2005). Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo. International Journal of Oncology. 27(1). 237–46. 39 indexed citations
14.
Lu, Baogen, Sharmila Makhija, Dirk M. Nettelbeck, et al.. (2005). Evaluation of tumor-specific promoter activities in melanoma. Gene Therapy. 12(4). 330–338. 47 indexed citations
15.
Zhu, Zeng B., Sharmila Makhija, Baogen Lu, et al.. (2004). Transcriptional targeting of tumors with a novel tumor-specific survivin promoter. Cancer Gene Therapy. 11(4). 256–262. 86 indexed citations
16.
Zhu, Zeng B., Sharmila Makhija, Baogen Lu, et al.. (2004). Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis. Virology. 325(1). 116–128. 35 indexed citations
17.
Haviv, Yosef S., Winan J. van Houdt, Baogen Lu, David T. Curiel, & Zeng B. Zhu. (2004). Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter. Molecular Cancer Therapeutics. 3(6). 687–691. 23 indexed citations
18.
Makhija, Sharmila, Baogen Lu, Lyudmila N. Kaliberova, et al.. (2004). Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter. Gene Therapy. 11(7). 645–648. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfgang Ebel Breakdown of academic impact, for papers by Friederike Herbst Breakdown of academic impact, for papers by Radhashree Maitra Breakdown of academic impact, for papers by Kenneth Garson Breakdown of academic impact, for papers by Joseph Briggs Breakdown of academic impact, for papers by Gary Owen Breakdown of academic impact, for papers by Chelsea K. Martin Breakdown of academic impact, for papers by Joelle M. Fenger Breakdown of academic impact, for papers by Natalie Erdmann Breakdown of academic impact, for papers by Alexis J. Carulli
Rankless by CCL
2026